Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.
about
Bronchiectasis in COPD patients: more than a comorbidity?Prevalence and associated factors of COPD among Aboriginal peoples in Canada: a cross-sectional study.Chronic Respiratory Infection in Patients with Chronic Obstructive Pulmonary Disease: What Is the Role of Antibiotics?Optimizing bronchodilation in the prevention of COPD exacerbationsJournal Club: Inhaled Corticosteroids- Refining Our Understanding of Their Role in Maintenance Treatment for COPD.Prospective comparison of non-invasive risk markers of major cardiovascular events in COPD patients.Impulse oscillometry system as an alternative diagnostic method for chronic obstructive pulmonary disease.Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC study.Evaluation of clinical variables according to follow-up times in COPD: results from ON-SINT cohort.A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease.Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis.Russian guidelines for the management of COPD: algorithm of pharmacologic treatment.Circulating miR-125b but not miR-125a correlates with acute exacerbations of chronic obstructive pulmonary disease and the expressions of inflammatory cytokines.What Can We Apply to Manage Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Acute Respiratory Failure?Profile of epigenetic mechanisms in lung tumors of patients with underlying chronic respiratory conditions.Understanding of COPD among final-year medical students.Muscle regeneration potential and satellite cell activation profile during recovery following hindlimb immobilization in mice.Diagnosing alpha-1 antitrypsin deficiency: the first step in precision medicine.HIF1A rs10873142 polymorphism is associated with risk of chronic obstructive pulmonary disease in a Chinese Han population: a case-control study.Protective effects of tiotropium alone or combined with budesonide against cadmium inhalation induced acute neutrophilic pulmonary inflammation in rats.Depressive status explains a significant amount of the variance in COPD assessment test (CAT) scores.Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.Prognostic implication of FEV1/FVC ratio for limited-stage small cell lung cancer.Pulmonary arterial enlargement predicts long-term survival in COPD patients.Reliability and usefulness of spirometry performed during admission for COPD exacerbation.Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations.Can muscle protein metabolism be specifically targeted by nutritional support and exercise training in chronic obstructive pulmonary disease?Relevance of nutritional support and early rehabilitation in hospitalized patients with COPD.Muscle atrophy in chronic obstructive pulmonary disease: molecular basis and potential therapeutic targets.Is It Time to Change the Definition of Acute Exacerbation of Chronic Obstructive Pulmornary Disease? What Do We Need to Add?Can muscle protein metabolism be specifically targeted by exercise training in COPD?Optimal Bronchodilation for COPD Patients: Are All Long-Acting β₂-Agonist/Long-Acting Muscarinic Antagonists the Same?Community Assessment of COPD Health Care (COACH) study: a clinical audit on primary care performance variability in COPD care.Alpha-1 antitrypsin deficiency: outstanding questions and future directions.Isoliquiritigenin Inhibits Cigarette Smoke-Induced COPD by Attenuating Inflammation and Oxidative Stress via the Regulation of the Nrf2 and NF-κB Signaling PathwaysSignificant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort studyPopulation-based study of LAMA monotherapy effectiveness compared with LABA/LAMA as initial treatment for COPD in primary careWhat have we learned from observational studies and clinical trials of mild to moderate COPD?Asthma-COPD overlap: identification and optimal treatmentFrailty assessment in older adults with chronic obstructive respiratory diseases
P2860
Q33704105-B60972A7-01F2-4332-AA1A-106D8A9B0717Q33884398-8CD5F609-54F8-45EC-8571-B95AF3E5CD5EQ38667550-C005CBC6-96A1-4DD0-983B-7B68F01EB8D0Q39386571-A1EECFAF-F20A-482E-B103-9DD180CC60D0Q41434144-14688940-836D-49C2-ADE5-7CE348A16272Q42368163-06B0DB02-58C5-4034-858F-DD39C716D73FQ47099184-91EF8BF0-B782-4574-83EB-4CB25D82AE75Q47103157-E77601A3-71BD-4A8C-B631-2D082D899F71Q47131947-A0F23A16-BEC7-49A3-B0DF-6430DF3F54F5Q47138049-E6DF0A1E-C1E4-4453-8A81-5FAE72484F44Q47159721-7BD76080-CB6F-4B56-A534-E41ACE6BE509Q47553955-E2DF9EED-04F3-4D27-9DFB-F595E0E2C91FQ47640362-213B6B9E-F409-439B-9EF7-21578BFA4BB1Q47646670-093DC159-2785-4C70-BEB3-1E40BE323B34Q47646903-85A22A66-1AE6-4129-89DF-6A32D36D881FQ47654420-90AB0903-DFEB-4C37-850B-C6100D9860C1Q47707727-D06185C2-6E00-400E-824C-1B1FC9C41D6DQ49961017-0D42F78A-D8AD-468F-8D8A-C903F71A9885Q50020582-A0A116DD-98B7-4E04-9895-70A5ABFAB3E3Q51746457-38C810AE-6BA4-4BA6-9C47-0EA3F628A8C4Q52347115-16B36D0B-A247-47C9-99AB-3109158BAA9BQ52684260-097456C7-AED0-4E53-ACB9-15D3889CC0C7Q52715752-51FE593D-B3B3-413D-A65A-DC06E01A0EDCQ54940823-5DFE52F4-6B22-42E5-89EE-2089E1218A3CQ55083893-F677510A-EACE-4B2C-8164-2FC944D28D4DQ55212210-1F973B23-7E64-4E90-9566-9FB4B9FBD640Q55287274-59DD0217-1436-435C-8D0D-229FDC31D79BQ55347346-1DBD7E06-32E0-48C5-B052-8D1A3DB3E283Q55397599-535B037E-8D07-4F58-9FD0-87B6CDCCF30BQ55415106-BE7080E8-FAC0-4202-83FF-9305456EAEAAQ55415720-69EBFF50-77E5-497E-8B5B-8BCC8CC35772Q55432750-1CB32ED1-40FA-4B5B-902F-F0FAAC6E9F14Q55517793-739FC58E-6A16-490C-9932-8D0158F1DF91Q55666746-84C642FF-9D60-4551-8AC2-88455AA835B7Q57191810-3F085751-4FE7-47BD-94A5-B6AFD8DE7122Q57212809-A5F14B08-1A6C-490F-BC28-AEA1AAFE64F2Q57777292-7A6A3E30-66D1-4B4B-A3FF-8C90F7AAA56BQ57777296-6415419C-3F09-48FF-8A91-07DCCC84FFBFQ58583993-5E63ADF0-0F95-48C3-8BA6-EB8BF51C4A2EQ58694396-D85BA8B6-FB5D-44A9-9EC6-A4FA421F42C6
P2860
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Global Strategy for the Diagno ...... eport: GOLD Executive Summary.
@en
type
label
Global Strategy for the Diagno ...... eport: GOLD Executive Summary.
@en
prefLabel
Global Strategy for the Diagno ...... eport: GOLD Executive Summary.
@en
P2093
P1476
Global Strategy for the Diagno ...... eport: GOLD Executive Summary.
@en
P2093
Alvar Agustí
Bartolome R Celli
Claus F Vogelmeier
Dave Singh
David M G Halpin
Fernando J Martínez
Gerard J Criner
Jadwiga A Wedzicha
Jean Bourbeau
P304
P356
10.1016/J.ARBR.2017.02.001
P577
2017-03-05T00:00:00Z